ArticleJournal of human hypertension2025
Cerebrovascular reactivity impairment in resistant hypertension.
Article in Journal of human hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Resistant hypertension (RH) is defined as office systolic blood pressure (BP) that remains uncontrolled despite the concurrent use of three or more antihypertensive drug classes and may be associated with altered vasomotor responses to physiological stimuli. However, the effect of RH on cerebrovascular reactivity (CVR) remains poorly understood. Furthermore, the potential contribution of autonomic nervous system dysfunction to these alterations has not yet been fully clarified. Understanding these mechanisms may offer insights into the pathophysiology of resistant hypertension and could have important prognostic implications. This study aims to analyze CVR in a cohort of patients with RH, compared with patients with non-resistant hypertension (NRH), taking into account the differences in sympathovagal balance between the two groups. Forty consecutive hypertension patients, 20 with NRH and 20 with RH, underwent heart rate variability analysis and transcranial color-coded Doppler at rest and during a breath-holding maneuver to evaluate CVR. Hypertensive individuals presented a significant reduction of the Breath Holding Index (BHI) and time-domain parameters (SDNN and SDANN) in comparison to the control group (BHI control 1.32 ± 0.41 vs hypertensive 0.92 ± 0.65; p = 0.018; SDANN control 125.76 ± 24.96 vs hypertensive 87.65 ± 20.63; p < 0.0001). RH patients presented a significant reduction in BHI (NRH BHI 1.15 ± 0.65 vs RH BHI 0.70 ± 0.58; p = 0.027) and HRV parameters (SDANN in NRH 95.09 ± 22.12 vs RH 80.21 ± 16.36; p = 0.021). Our results show that RH is associated with impaired HRV and CRV. Autonomic dysfunction could be a concurrent cause of cerebral vasomotor reactivity impairment.
Indexed as
Identifiers
40753122What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.